Patents by Inventor Shixiang Wang

Shixiang Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10131619
    Abstract: The present invention relates to ?-asary-laldehyde ester. The chemical structure of the related ?-asary-laldehyde ester is of formula I.
    Type: Grant
    Filed: November 26, 2015
    Date of Patent: November 20, 2018
    Assignee: NORTHWEST UNIVERSITY
    Inventors: Xiaohui Zheng, Fanggang Qin, Yajun Bai, Shixiang Wang, Yi Zhang, Xirui He, Pei Liu
  • Publication number: 20170260122
    Abstract: The present invention relates to ?-asary-laldehyde ester, a preparation method therefor, and an application thereof. The chemical structure of the related ?-asary-laldehyde ester is represented by formula I. A related application is an application of the compound in preparation of drugs for calming, mind tranquillizing, senile dementia resisting, convulsion resisting, epilepsy resisting and depression resisting.
    Type: Application
    Filed: November 26, 2015
    Publication date: September 14, 2017
    Applicant: NORTHWEST UNIVERSITY
    Inventors: Xiaohui ZHENG, Fanggang QIN, Yajun BAI, Shixiang WANG, Yi ZHANG, Xirui HE, Pei LIU
  • Patent number: 8017786
    Abstract: The present invention relates to a compound of the formula (I), wherein R1, R2 and R3 are each independently selected from H, OH, F, Cl, Br, methoxy and ethoxy; or alternatively, R1 and R2 together form —OCH2O—, R3 is selected from H, OH, methoxy, ethoxy and halogens; R4 is OH or acyloxy; R5 is cycloalkoxyl, amino and substituted amino, and when R5 is selected from amino, at least one of R1, R2 and R3 is not H. The present invention further relates to a process for synthesizing a compound of the formula (I), and use of the compound of the formula (I) in the manufacture of a medicament for the prevention or treatment of cardiovascular or cerebrovascular diseases.
    Type: Grant
    Filed: May 14, 2007
    Date of Patent: September 13, 2011
    Assignee: Northwest University
    Inventors: Xiaohui Zheng, Qunzheng Zhang, Shixiang Wang, Xinfeng Zhao
  • Publication number: 20090131677
    Abstract: The present invention relates to a compound of the formula (I), wherein R1, R2 and R3 are each independently selected from H, OH, F, Cl, Br, methoxy and ethoxy; or alternatively, R1 and R2 together form —OCH2O—, R3 is selected from H, OH, methoxy, ethoxy and halogens; R4 is OH or acyloxy; R5 is cycloalkoxyl, amino and substituted amino, and when R5 is selected from amino, at least one of R1, R2 and R3 is not H. The present invention further relates to a process for synthesizing a compound of the formula (I), and use of the compound of the formula (I) in the manufacture of a medicament for the prevention or treatment of cardiovascular or cerebrovascular diseases.
    Type: Application
    Filed: May 14, 2007
    Publication date: May 21, 2009
    Applicant: NORTHWEST UNIVERSITY
    Inventors: Xiaohui Zheng, Qunzheng Zhang, Shixiang Wang, Xinfeng Zhao